These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18779052)

  • 1. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.
    Lisco A; Vanpouille C; Tchesnokov EP; Grivel JC; Biancotto A; Brichacek B; Elliott J; Fromentin E; Shattock R; Anton P; Gorelick R; Balzarini J; McGuigan C; Derudas M; Götte M; Schinazi RF; Margolis L
    Cell Host Microbe; 2008 Sep; 4(3):260-270. PubMed ID: 18779052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coinfection alters the playing field: herpesviruses induce acyclovir to inhibit HIV.
    Stapleton JT; Balfour HH
    Cell Host Microbe; 2008 Sep; 4(3):194-5. PubMed ID: 18779044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.
    Vanpouille C; Lisco A; Derudas M; Saba E; Grivel JC; Brichacek B; Scrimieri F; Schinazi R; Schols D; McGuigan C; Balzarini J; Margolis L
    J Infect Dis; 2010 Feb; 201(4):635-43. PubMed ID: 20085496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides.
    Derudas M; Vanpouille C; Carta D; Zicari S; Andrei G; Snoeck R; Brancale A; Margolis L; Balzarini J; McGuigan C
    J Med Chem; 2017 Sep; 60(18):7876-7896. PubMed ID: 28829913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.
    Vanpouille C; Lisco A; Introini A; Grivel JC; Munawwar A; Merbah M; Schinazi RF; Derudas M; McGuigan C; Balzarini J; Margolis L
    Antimicrob Agents Chemother; 2012 May; 56(5):2604-11. PubMed ID: 22314523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity.
    Balzarini J; Andrei G; Balestra E; Huskens D; Vanpouille C; Introini A; Zicari S; Liekens S; Snoeck R; Holý A; Perno CF; Margolis L; Schols D
    PLoS Pathog; 2013; 9(7):e1003456. PubMed ID: 23935482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase.
    Tchesnokov EP; Obikhod A; Massud I; Lisco A; Vanpouille C; Brichacek B; Balzarini J; McGuigan C; Derudas M; Margolis L; Schinazi RF; Götte M
    J Biol Chem; 2009 Aug; 284(32):21496-504. PubMed ID: 19509419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover Trial.
    Vanpouille C; Lisco A; Grivel JC; Bassit LC; Kauffman RC; Sanchez J; Schinazi RF; Lederman MM; Rodriguez B; Margolis L
    Clin Infect Dis; 2015 Jun; 60(11):1708-14. PubMed ID: 25740794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyclovir: a new use for an old drug.
    Vanpouille C; Lisco A; Margolis L
    Curr Opin Infect Dis; 2009 Dec; 22(6):583-7. PubMed ID: 19726982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of V75I HIV-1 reverse transcriptase mutant selected in vitro by acyclovir to anti-HIV drugs.
    McMahon MA; Siliciano JD; Kohli RM; Siliciano RF
    AIDS; 2010 Jan; 24(2):319-23. PubMed ID: 20009920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
    Bourinbaiar AS; Coleman CF
    Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
    Balzarini J; Haller-Meier F; De Clercq E; Meier C
    Antivir Chem Chemother; 2001 Sep; 12(5):301-6. PubMed ID: 11900349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition.
    Derudas M; Carta D; Brancale A; Vanpouille C; Lisco A; Margolis L; Balzarini J; McGuigan C
    J Med Chem; 2009 Sep; 52(17):5520-30. PubMed ID: 19645484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Virology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate.
    Callebaut C; Stepan G; Tian Y; Miller MD
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5909-16. PubMed ID: 26149992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme.
    Diez-Torrubia A; Cabrera S; de Castro S; García-Aparicio C; Mulder G; De Meester I; Camarasa MJ; Balzarini J; Velázquez S
    Eur J Med Chem; 2013; 70():456-68. PubMed ID: 24185376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
    Andrei G; Gillemot S; Topalis D; Snoeck R
    J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
    Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN
    Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
    Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K
    Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.
    Meng Q; Hagemeier SR; Fingeroth JD; Gershburg E; Pagano JS; Kenney SC
    J Virol; 2010 May; 84(9):4534-42. PubMed ID: 20181711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.